BCAB Stock: BioAtla, Inc. Stock Price, Analysis & Insights
Get live bcab stock price $1.10, comprehensive BioAtla, Inc. stock analysis, charts, news, and expert forecast. Real-time bcab stock data and investment insights.
Loading chart...
Company Overview
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.
Company Information
- CEO
- Jay M. Short
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 61
Contact Information
- Website
- https://www.bioatla.com
- Address
- 11085 Torreyana Road
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
BioAtla, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Jay M. Short, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
BioAtla, Inc. competes in the Biotechnology within the broader Healthcare. With 64.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Market, BioAtla, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating BioAtla, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BioAtla, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BioAtla, Inc.
- ⚠Investors should consider how BioAtla, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
64.59M
P/E Ratio
-1.00
Beta
1.03
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 64.59M market capitalization
- Trading Volume: 971.14K shares traded today
- Price Range: 52-week range of $0.24 - $1.90
- Exchange: Listed on NASDAQ Global Market
Financial Metrics
Market Analysis for BioAtla, Inc.
BioAtla, Inc. (BCAB) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 64.59M, the company represents a significant player in its market. The stock is currently trading at $1.10 with a positivedaily change of 7.83%.
The company's 61 employee base and presence on the NASDAQ Global Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -1.00, beta of 1.03, and 52-week price range from $0.24 to $1.90when evaluating investment opportunities.
Why Invest in BioAtla, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Market)
- • Experienced leadership under Jay M. Short
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.